Abstract
Paraffin sections from 30 human breast tissue specimens were stained with a specific antibody for thymosin beta-10, ATB10(38-43). The results showed that thymosin beta-10 was detected mainly in the malignant tissue, particularly in the cancerous cells, whereas the normal cell population around the lesions showed very weak staining. Also, the intensity of staining in the cancerous cells was proportionally increased with the increasing grade of the lesions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Verghese-Nikolakaki, S., Apostolikas, N., Livaniou, E. et al. Preliminary findings on the expression of thymosin beta-10 in human breast cancer. Br J Cancer 74, 1441–1444 (1996). https://doi.org/10.1038/bjc.1996.562
Issue Date:
DOI: https://doi.org/10.1038/bjc.1996.562
This article is cited by
-
Thymosin beta 10 is a key regulator of tumorigenesis and metastasis and a novel serum marker in breast cancer
Breast Cancer Research (2017)
-
High expression of thymosin beta 10 predicts poor prognosis for hepatocellular carcinoma after hepatectomy
World Journal of Surgical Oncology (2014)
-
Suppression of thymosin β10 increases cell migration and metastasis of cholangiocarcinoma
BMC Cancer (2013)
-
Thymosin β4 and angiogenesis: modes of action and therapeutic potential
Angiogenesis (2007)
-
Overexpression of the thymosin β-4 gene is associated with malignant progression of SW480 colon cancer cells
Oncogene (2003)
